cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Urogen Pharma Ltd
2 own
4 watching
Current Price
$13.31
$0.04
(0.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
464.06M
52-Week High
52-Week High
24.13000
52-Week Low
52-Week Low
8.69000
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization464.06M
icon52-Week High24.13000
icon52-Week Low8.69000
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Urogen Pharma Ltd do?
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company s lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Read More
How much money does Urogen Pharma Ltd make?
News & Events about Urogen Pharma Ltd.
Business Wire
11 months ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (RSUs) to 6 new employees in connection with their employment with...
Business Wire
1 year ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest post-commercial utilization review of JELMYTO (mitomycin) for...
Ticker Report
1 year ago
UroGen Pharma Ltd. (NASDAQ:URGN Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 743,700 shares, an increase of 16.3% from the March 31st total of 639,500 shares. Based on an average daily trading ...
Business Wire
1 year ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest post-commercial utilization review of JELMYTO (mitomycin) for...
Business Wire
1 year ago
UroGen Pharma Ltd. (Nasdaq: URGN) a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (RSUs) to 7 new employees in connection with their entering into...
Frequently Asked Questions
Frequently Asked Questions
What is Urogen Pharma Ltd share price today?
plus_minus_icon
Can Indians buy Urogen Pharma Ltd shares?
plus_minus_icon
How can I buy Urogen Pharma Ltd shares from India?
plus_minus_icon
Can Fractional shares of Urogen Pharma Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Urogen Pharma Ltd stocks?
plus_minus_icon
What is today’s traded volume of Urogen Pharma Ltd?
plus_minus_icon
What is today’s market capitalisation of Urogen Pharma Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Urogen Pharma Ltd?
plus_minus_icon
What percentage is Urogen Pharma Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Urogen Pharma Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$13.31
$0.04
(0.3%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00